AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

PRFX · NASDAQ · Drug Manufacturers - Specialty & Generic

PRF Technologies (PRFX)

Develops sustained-release therapies and software for solar-asset monitoring and optimization.

$0.9600

Pre-market+0.01 (+1.02%)

At close$0.9503(−0.09%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Institutions4 holders · as of Mar 31, 2026	94.75%	15.7K ADS
	Otherremainder	5.25%	872 ADS

16.6K ADS (1 ADS = 10 ordinary shares) as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (16.6K in the company's Sep 3, 2026 report, 80.5K elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Citadel Advisors LLCInstitution	79.58%	13,220 ADS	13Fas of Mar 31, 2026
Morgan StanleyInstitution	9.70%	1,611 ADS	13Fas of Mar 31, 2026
UBS Group AGInstitution	5.23%	869 ADS	13Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution	0.24%	40 ADS	13Fas of Mar 31, 2026
Armistice Capital, LLCStrategic	—9.99% of class, as filed	—	13D/Gfiled Feb 14, 2024 ↗
B. AsherInsider	—7.90% of class, as filed	—	13Gfiled Apr 24, 2024 ↗
Medica III Investments (S.F.) L.P.Institution	—31.40% of class, as filed	—	13D/Gfiled Feb 11, 2022 ↗
XT Holdings Ltd.Strategic	—19.70% of class, as filed	—	13D/Gfiled Nov 4, 2020 ↗
YA II PN, Ltd.Strategic	—9.99% of class, as filed	—	13Gfiled Jun 22, 2026 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

4 holders · 15.7K shares

Holder	Shares	% outstanding	Filed
Citadel Advisors LLC	13.2K	79.58%	May 15, 2026
Morgan Stanley	1.6K	9.70%	May 15, 2026
UBS Group AG	869	5.23%	May 5, 2026
Advisor Group Holdings, Inc.	40	0.24%	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
YA II PN, Ltd.	9.99%		13G	Jun 22, 2026 ↗

PRF Technologies (PRFX)

Breakdown13F · 13D/G · Form 4

Top shareholders13F · 13D/G · Form 4

Institutions13F, as of Mar 31, 2026

Ownership statements13D/G · 5% or more, as filed

Insider tradesForm 4

Latest trades

CongressHouse and Senate disclosures